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Abstract: Development of ion-releasing implantable biomaterials is a valuable approach for advanced
medical therapies. In the effort of tackling this challenge, we explored the feasibility of porous bioceramic
scaffolds releasing copper ions, which are potentially able to elicit angiogenetic and antibacterial effects.
First, small amounts of CuO were incorporated in the base silicate glass during melting and the obtained
powders were further processed to fabricate glass–ceramic scaffolds by sponge replica method followed
by sinter crystallization. As the release of copper ions from these foams in simulated body fluid (SBF) was
very limited, a second processing strategy was developed. Silicate glass–ceramic scaffolds were coated
with a layer of Cu-doped mesoporous glass, which exhibited favorable textural properties (ultrahigh
specific surface area >200 m2/g, mesopore size about 5 nm) for modulating the release of copper. All the
produced scaffolds, containing biocompatible crystals of wollastonite (CaSiO3), revealed high stability
in a biological environment. Furthermore, the materials had adequate compressive strength (>10 MPa)
for allowing safe manipulation during surgery. Overall, the results achieved in the present work suggest
that these Cu-doped glass-derived scaffolds show promise for biomedical application and motivate
further investigation of their suitability from a biological viewpoint.
Keywords: bioactive glass; glass–ceramic; scaffold; mesoporous; copper; angiogenesis; antibacterial;
bioactivity; orbital implants
1. Introduction
Over the last few years, understanding the biological role played by ionic dissolution products
released from implantable biomaterials has become one of the most challenging topics in the context of
tissue engineering applications. As many trace elements are involved in cell metabolic processes [1,2],
their controlled delivery at the implant site can be exploited to elicit specific therapeutic responses in
the host (patient), such as improved osteogenesis (e.g., Ca and Si [3]), angiogenesis (e.g., Co [4]) or
antibacterial properties (e.g., Ag [5]).
Bioactive glasses are ideal matrices for embedding therapeutic metallic ions that can be added
during the glass synthesis via either the melt-quenching route or the sol-gel method. Comprehensive
overviews of these topics have been recently reported by different research groups [6–9].
Interestingly, some metallic ions can take part in multiple biological processes and, thereby,
are potentially able to exert a multifunctional therapeutic action. A typical example is represented
by copper, which is able to both elicit an antimicrobial effect and to stimulate angiogenesis. It has
been found that copper ions are able to kill bacteria through the generation of reactive oxygen species
(ROS), lipid peroxidation, protein oxidation and DNA degradation [10]. Furthermore, copper ions
were shown to promote angiogenesis both in vitro and in vivo through implementing hypoxia-like
conditions, which are followed by upregulation of various matrix metalloproteinases (e.g., MMP-2)
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and thereby result in extracellular matrix (ECM) degradation as well as the stalk endothelial cell
proliferation and migration [11].
Most studies dealing with Cu-doped bioactive glasses address to applications in contact with
bone; specifically, melt-derived powders [12], hierarchical macromesoporous scaffolds [13] and
spray-dried nano-sized spheres [14] have been investigated. However, less popular but highly
intriguing applications exist where combining improved angiogenesis with antibacterial properties
is key for postoperative success, such as orbital implants in ophthalmic surgery. These ocular
implants, exhibiting a spherical or egg-like shape, are inserted in the patient’s orbital socket to restore
eyeball volume after surgical enucleation [15]. Whenever possible, orbital implants are sutured to the
spared extraocular muscles so that the implant movement can be transmitted to an aesthetic ocular
prosthesis—connected to the implant—which replicates the appearance of the healthy contralateral eye.
Orbital implants should ideally remain in situ over the whole life of adult patients without undergoing
any significant degradation over time; hence, clinically-used implants include non-resorbable materials
such as porous hydroxyapatite, polyethylene or alumina [16]. The presence of a three-dimensional
(3D) network of open macropores allows the ingrowth of fibrovascular tissue, which is key to firmly
anchor the implant (scaffold) to soft orbital tissues and to provide a blood supply within the implant,
thereby diminishing the risk of infection and promoting the spontaneous healing of small conjunctival
exposures [17]. Despite all these advantages, commercial porous orbital implants still suffer from
a non-negligible failure rate [18] and are highly expensive, thereby often pushing patients to choose
other cheaper solutions, such as solid polymeric spheres that, however, do not allow fibrovascular
ingrowth and are potentially susceptible to a higher risk of infection.
Therefore, there is the need for developing novel porous orbital implants that could lead to
better performances compared to the existing options. This challenge is tackled in the present work
that reports the feasibility and physicochemical characterization of Cu-doped porous glass–ceramic
scaffolds and discusses their potential suitability as orbital implant materials. It is worth underlining
that, for this purpose, we tried to fulfil two apparently irreconcilable requirements, i.e., the need for
a permanent material combined with the release of copper ions over time.
2. Materials and Methods
The basic material used for scaffold preparation was a melt-derived silicate glass belonging to
the 57SiO2-34CaO-6Na2O-3Al2O3 (mol. %) system (SCNA). This choice was performed based on the
primary requirement needed for an orbital implant, i.e., the absence of significant degradation over
time during contact with biological fluids. SCNA, initially developed for osseous applications and
exhibiting an almost-inert behavior in vitro [19], was thought potentially suitable for use as orbital
implant material, too.
Copper was embedded in the SCNA-derived scaffolds through two different approaches:
(i) incorporation of copper during the melting of the glass that will be used to produce scaffolds; or (ii)
coating of the scaffold with a Cu-containing sol-gel derived mesoporous bioactive glass (xCu-MBG,
x = 1 or 5 mol. %) layer.
2.1. First Strategy: Preparation of Scaffolds Based on Cu-Containing Melt-Derived Glasses Ubsection
The SCNA-based glass-forming batches were prepared by mixing analytical grade SiO2, Al2O3,
CaCO3 and Na2CO3 along with proper amounts of CuO (all purchased from Sigma-Aldrich, St. Louis,
MO, USA). Copper-doped glasses were obtained by varying the CaO-to-CuO molar ratio. Specifically,
two Cu-doped glasses were produced, i.e., SCNA-2Cu (57SiO2-32CaO-6Na2O-3Al2O3-2CuO mol. %)
and SCNA-5Cu (57SiO2-29CaO-6Na2O-3Al2O3-5CuO mol. %). The raw materials (powders) were
weighed and subsequently mixed in an orbital shaker to ensure adequate homogenization of the
blends. The mixtures of oxides and carbonates were placed in alumina crucibles with a lid and heated
up to 1550 ◦C for about 30 min in an electric furnace; then, the crucibles were taken out of the furnace
and the melt was quenched in cold water to obtain glass frits.
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After being dried at room temperature, the glass was placed in a zirconium oxide milling jar and
pulverized in a planetary mill (Pulverisette 6, Fritsch, Idar-Oberstein, Germany) at 300 rpm for a total
time of 70 min. Afterwards, the powders were manually sieved through stainless steel sieves (Giuliani
Technologies, Torino, Italy) in order to obtain a final particle size below 32 µm.
Porous SCNA, SCNA-2Cu and SCNA-5Cu scaffolds were fabricated from respective starting glasses
via sponge replica method. Briefly, this technique involves the impregnation of an open-cell polymeric
sponge with a slurry containing glass particles and a binder in order to coat the walls and struts of the
sponge with a thin layer of glass. The sponge is then dried and the resulting green body is heat-treated in
order to eliminate the polymeric template and to sinter and (partially) crystallize the glass particles.
Specifically, the glass suspensions were prepared by mixing glass powders (40 wt. %), polyvinyl
alcohol (PVA) (6 wt. %) and distilled water (54 wt. %) along with a small amount (0.1 wt. % of total
solid loading) of a dispersant/deflocculant agent (Dolapix CE 64, Zschimmer and Schwarz GmbH,
Lahnstein, Germany). First, PVA was dissolved in water under magnetic stirring (200 rpm) for 1 h at
90 ◦C; at the end of this stage, the same amount of liquid water as that evaporated during mixing was
re-added to the batch in order to maintain the initial mass ratio, then, glass powders and Dolapix were
dispersed into the batch that was stirred for 0.5 h to obtain a homogeneous slurry.
A commercial open-cell polyurethane (PU) sponge of 45 ppi (pores per inch) was manually cut
into 10 mm × 10 mm × 10 mm cuboids that were dipped into the slurry. After withdrawal, the excess
slurry was removed by cycles of compression (20 kPa for 1 s) to reduce the sponge thickness up to 60%
along the three spatial directions. This infiltration-compression cycle was repeated three times; then,
the glass-coated polymeric cuboids were left to dry overnight at room temperature and heated up to
1000 ◦C (SCNA-2Cu) or 950 ◦C (SCNA-5Cu) for 3 h in an electric furnace in air (heating rate 5 ◦C/min)
to burn out the PU foam and sinter the glass particles.
2.2. Second Strategy: Scaffolds Coated with xCu-MBGs
The process used for the synthesis of xCu-MBG was a sol-gel-type route commonly referred to as
evaporation-induced self-assembly (EISA) method. xCu-MBG were prepared by incorporating CuO
to partially replace CaO in the MBG composition (molar ratio Si/Ca/Cu = 80/19/1 and 80/15/5 for
1Cu-MBG and 5Cu-MBG, respectively).
The classical synthesis procedure reported by Yan et al. [20] was followed as a base reference
and properly modified to incorporate copper in the mesoporous glass. The synthesis involved the
use of a commercially available surfactant (Pluronic P123) as a structure-directing agent. Tetraethyl
orthosilicate (TEOS) and calcium nitrate tetrahydrate Ca(NO3)2·4H2O were used to supply SiO2 and
CaO, respectively, while CuO was sourced as CuCl2 (all the reagents were purchased from Sigma-Aldrich,
St. Louis, MO, USA). Briefly, 4.0 g of P123 were dissolved in 60.0 g of ethanol with 1.0 g of 0.5 M HCl
under constant stirring at room temperature. Once P123 was completely dissolved, the glass precursors
were slowly added in the following order: 6.7 g of TEOS, 1.8 or 1.425 g of Ca(NO3)2·4H2O (for 1Cu-MBG
or 5Cu-MBG, respectively), and 0.054 or 0.27 g of CuCl2 (for 1Cu-MBG or 5Cu-MBG, respectively).
The xCu-MBG coatings were applied on SCNA scaffolds by completely immersing them into
the sol for 10 min. After withdrawal, the scaffolds were left to dry at room temperature for 24 h.
This immersion-drying cycle was repeated for three time. Eventually, the scaffolds were calcined at
650 ◦C for 5 h in air (heating and cooling rate of 2 ◦C/min and 5 ◦C/min, respectively) to obtain
xCu-MBG-coated SCNA scaffolds.
2.3. Characterizations
2.3.1. Hot-Stage Microscopy
The hot-stage microscopy (HSM) measurements were carried out on Cu-doped melt-derived
glasses by using a heating stage optical microscope equipped with image analysis system (Expert System
Solutions, Modena, Italy). SCNA-2Cu and SCNA-5Cu cylindrical specimens suitable for the analysis
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(diameter 2 mm, height 3 mm) were obtained by manually pressing the glass powders (particle size < 32µm)
in a stainless steel mould and then positioned onto a high-purity alumina plate. Black-and-white
images (silhouettes) of the profile of the specimens were taken from 25 to 1400 ◦C with a heating rate
of 10 ◦C/min. The variation of the sample dimensions upon heating were measured and the shrinkage
(%) was quantified, along with the temperature of first shrinkage (TFS) and maximum shrinkage (TMS).
This analysis was key to select the appropriate sintering temperature for fabricating the scaffolds.
2.3.2. Microstructural Analysis
Powdered materials underwent X-ray diffraction (XRD) by using a X’Pert Pro PW3040/60
diffractometer (PANalytical, Eindhoven, The Netherlands) operating at 40 kV and 30 mA with
Bragg-Brentano camera geometry and Cu Kα incident radiation (wavelength λ = 0.15405 nm).
Identification of crystalline phases was performed by using X’Pert HighScore software (2.2b) equipped
with the PCPDFWIN database (http://pcpdfwin.updatestar.com).
Wide-angle XRD (2θ within 10–70◦) was performed on melt-derived materials (SCNA-2Cu and
SCNA-5Cu), while small-angle XRD (2θ within 0.9–5◦) was applied to assess the presence of an ordered
mesoporous structure in the mesoporous coating.
2.3.3. Morphology, Composition and Porosity
Scanning electron microscopy (SEM; SupraTM 40, Zeiss, Oberkochen, Germany) was used to
evaluate the morphology of both scaffolds and coatings as well as the pore/strut characteristics of the
scaffolds. Compositional analysis was performed by energy dispersive spectroscopy (EDS), which was
included in the SEM equipment. The samples were silver-coated prior to the analysis and inspected at
an accelerating voltage in the range of 5 to 15 kV.
The 3D pore/strut architecture of the scaffolds was also investigated by means of X-ray
micro-computed tomography (micro-CT). Scans were performed by using a commercial micro-CT unit
Skyscan 1174.v2 (SkyScan-Bruker, Kontich, Belgium). The major scanning parameters included fixed
rotation step 0.3◦, image pixel size 7.6 µm, exposure time 8500 ms, and 500-µm thick aluminum filter.
3D reconstruction and visualization were performed by using the NRecon and DataViewer/CTVox
softwares (SkyScan-Bruker, Kontich, Belgium), whereas the CTAn program (Bruker, Billerica, MA, USA)
was employed for 2D/3D processing and quantitative analysis of data.
Textural parameters of mesoporous coatings were assessed by nitrogen (N2) adsorption-desorption
porosimetry measurements performed at−196 ◦C (Quantachrome Autosorb1, Quantachrome, Boynton
Beach, FL, USA). The specific surface area (SSA) was assessed by using the Brunauer-Emmet-Teller
(BET) method [21], and the pore size distribution (along with the mean pore size) was determined
through the density functional theory (DFT) isotherm reconstruction approach [22]. The mesoporous
structure was also studied by means of scanning-transmission electron microscopy (STEM).
2.3.4. Mechanical Testing
The compressive strength of scaffolds was evaluated by means of crushing tests (Syntech 10/D
machine, MTS, Eden Prairie, MN, USA; cross-head speed set at 0.5 mm min−1) on polished cuboids as
LC/AC, where LC (N) is the maximum compressive load registered during the test and AC (mm2) is the
resistant cross-sectional area perpendicular to the load axis. Results are expressed as mean ± standard
deviation calculated on at least five samples for each type.
2.3.5. Copper Release Studies
Release of copper ions from the scaffolds soaked in simulated body fluid (SBF) was assessed
by means of inductively-coupled plasma-mass spectrometer (ICP-MS; iCAP™ Q spectrometer,
ThermoFisher Scientific, Waltham, MA, USA). SBF was prepared according to the protocol recommended
by Kokubo and Takadama [23]. The scaffolds (triplicate samples) were maintained in polyethylene
bottles filled with SBF at 37 ◦C in an incubator under static conditions; the copper release was
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monitored up to 30 days. A mass-to-volume ratio of 1.5 mg/mL was used, as recommended in previous
studies [24]. At each time point, 1 mL aliquot of solution was collected and replaced with fresh SBF,
as suggested in [24]. At the end of the experiment, the samples were extracted, rinsed with ultra-pure
water, left to dry overnight at room temperatures and analyzed by SEM-EDS. The solution aliquots
collected at each time point were analyzed by ICP-MS to determine copper elemental concentration.
3. Results and Discussion
3.1. Scaffolds Based on Cu-Containing Melt-Derived Glasses
HSM analysis guided the selection of the sintering treatment for the fabrication of SCNA-2Cu
and SCNA-5Cu scaffolds. As shown in Figure 1a, SCNA-2Cu and SCNA-5Cu samples maintained
their unaltered cylindrical shape up to 722 and 725 ◦C, respectively, when first shrinkage occurred.
Maximum shrinkage was reached within 820–830 ◦C and the samples underwent melting above
1190 ◦C. Figure 1b compares the thermal shrinkage of melt-derived Cu-doped glasses with that of
the parent SCNA material. The thermal behavior of the three glasses is similar as they all exhibit
a one-stage shrinkage upon heating, and the maximum shrinkage is followed by a plateau before
reaching the melting temperature. The first shrinkage temperature does not significantly change with
CuO content. Interestingly, decrease of the melting temperature was observed with the increasing
amount of CuO in substitution to CaO in the glass composition. This result is in accordance with those
obtained by Wers et al. [25]. CuO is known to be an intermediate oxide but, if there is a relatively low
amount of alkaline ions in the glass, Cu2+ participates only as a network modifier assuming the same
role as Ca2+ [26]. Therefore, the reduction of melting temperature with increasing amount of CuO can
be related to the difference of high-temperature stability of CaO and CuO. CaO is a widely accepted
refractory compound, conversely to CuO (the refractoriness of a compound reflects its melting point,
and in the case of CaO and CuO melting points are 2590 and 1326 ◦C, respectively). Based on the
HSM results, the selected sintering temperatures for making the scaffolds were 1000 and 950 ◦C for
SCNA-2Cu and SCNA-5Cu, respectively (well above the maximum shrinkage and in the middle of the
densification region).
As-poured SCNA-2Cu and SCNA-5Cu are completely amorphous materials (glasses),
as demonstrated by the broad halo (2θ within 20–40◦) in the wide-angle XRD patterns shown in
Figures 2a and 3a. Analogous results were found elsewhere for the parent SCNA material [27].
Therefore, it can be stated that the introduction of CuO in the glass matrix does not affect the
amorphous character of the glasses. The wide-angle XRD analyses performed on SCNA-2Cu and
SCNA-5Cu scaffolds ground in powders (Figures 2b and 3b) indicate that wollastonite (CaSiO3;
PDF code: 00-027-0088) is the major crystalline phase developed in both materials upon heat treatment.
This is consistent with previous observations on Cu-free crystallized SCNA [27] as well as with the
results reported by Pérez et al. (devitrification of a SiO2-CaO-Na2O-Al2O3 glass to wollastonite
within 850–950 ◦C) [28]. The biocompatibility of wollastonite is well known and recognized since the
1980s [29,30]. Labradorite (Ca0.65Na0.35(Al1.65Si2.35O8); PDF code: 01-083-1370) was also detected as
a secondary crystalline phase in heat-treated SCNA-5Cu. In summary, both scaffolds are actually made
of glass–ceramic materials.
Micro-CT investigations allowed visualizing the pore/strut structure of the scaffolds (Figure 4),
characterized by a 3D network of open and interconnected macropores with a size in the range of
450–500 µm (total porosity about 50 vol. %). The connectivity density of the scaffolds is around 3.0 mm−3
which, interestingly, is very close to that of femur trabecular bone from human patients [31,32]. In general,
pore interconnectivity is a key feature for implantable scaffolds to allow biological fluid perfusion,
cell colonization and blood vessel access. A comparison with the pore characteristics of commercial
implants supports the architectural suitability of Cu-doped SCNA-based scaffolds for orbital applications
(for example, the total porosity and pore size of Medpor® polyethylene implant are within 30–70 vol. %
and 100–1000 µm, while the bioceramic alumina implant has a nominal pore size centered at 500 µm [33]).
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Compressive strength of SCNA-2Cu and SCNA-5Cu scaffolds (23 ± 2 and 21 ± 3 MPa,
respectively) is enough to allow safe manipulation of the implants during surgical procedures.
Figure 1. Results of HSM: (a) silhouettes of the Cu-doped SCNA-based glasses sample at different
characteristic temperatures upon heating (TR room temperature, TFS first shrinkage, TS softening,
TMS maximum shrinkage, TFLOW flowing); (b) shrinkage variation as a function of temperature
(A0 area of the silhouette at room temperature, AT sample area at the current temperature).
Figure 2. Wide-angle XRD pattern of (a) as-quenched SCNA-2Cu and (b) SCNA-2Cu thermally treated
at 1000 ◦C for 3 h.
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Figure 3. Wide-angle XRD pattern of (a) as-quenched SCNA-5Cu and (b) SCNA-5Cu thermally treated
at 950 ◦C for 3 h.
Figure 4. Exemplary micro-CT analysis of the Cu-doped scaffolds: (a) 3D reconstruction of the scaffold
volume and (b) cross-sections in the [xy], [xz] and [yz] orthogonal planes.
Copper ion release from SCNA-2Cu and SCNA-5Cu scaffolds as a function of immersion time in
SBF is shown in Figure 5. In general, a continuous release over time was observed and the amount of Cu
ions in SBF increased with increasing amount of Cu in the as-prepared glass (SCNA-5Cu > SCNA-2Cu).
A quantitative evaluation of in vitro release of copper is essential in order to rationalize the effective
therapeutic properties of the materials. The therapeutic behavior, in fact, will depend on the amount
of copper ions released. Most of the studies existing in the literature reveal that an antimicrobial effect
can be obtained with a copper ion concentration within 50–100 ppm [13,34,35], which is significantly
higher compared to the values achieved for SCNA-2Cu and SCNA-5Cu. A similar situation was
observed as far as the angiogenetic effect is concerned: a clear promotion of angiogenesis was reported
in vitro and in vivo when the level of copper released is on the order of a few tens of ppm [13,36].
Detection of no mass loss at the end of the dissolution experiments for both types of scaffolds
further confirms the high stability of SCNA-2Cu and SCNA-5Cu in a biological environment, which can
be interesting when non-resorbable implants are needed (e.g., permanent orbital implants).
The high stability of these scaffolds in SBF and the low release of copper are dictated by the
basic SCNA composition. In principle, other less-stable melt-derived glasses could be selected
and doped with copper for improving the release of copper to therapeutic levels, thus eliciting
acceptable antibacterial and pro-angiogenic actions. However, these glass-derived materials would
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undergo progressive dissolution over time, which contradicts the main requirement of orbital implants
(high stability and structural integrity). Therefore, a completely different approach was investigated
based on the deposition of reactive but thin glass coatings on nearly-inert glass–ceramic scaffolds.
Figure 5. Profiles of copper release from SCNA-2Cu and SCNA-5Cu scaffolds following immersion
in SBF.
3.2. Scaffolds Coated with Cu-Doped MBGs
In order to increase the release of copper from the scaffolds, a second approach was pursued
involving the coating of SCNA scaffolds with a Cu-doped MBG layer. In fact, the mesoporous texture
and high SSA of mesoporous materials are known to intensify the rate of surface reactions compared to
melt-derived ones, thus leading to a faster release of therapeutic agents during glass dissolution [37].
The wide-angle XRD diffraction patterns of calcined 1Cu-MBG and 5Cu-MBG are shown in
Figure 6 and reveal the completely amorphous nature of both glasses, as demonstrated by the sole
presence of a broad halo (2θ within 15–35◦). On the contrary, in the small-angle regime (Figure 7a,b),
both glasses show the diffraction peaks typical of the scattering patterns of a two-dimensional
hexagonal p6mm lattice [20]. The d100 is about 6.8 nm for both materials and, assuming a 2D hexagonal
symmetry, the cell parameter results to be 7.8 nm. The low intensities for the reflections of 1Cu-MBG is
probably due to the lower order of the mesostructure compared to 5Cu-MBG. According to the available
literature, the effects of copper ions on the textural properties of MBGs still are under debate. Although
it was well shown that doping with copper leads to a decrease of SSA compared to mesoporous
pure silica, clear relationships between the increasing content of copper and the mesostructural order,
SSA and mesopore size remain to be fully understood [13,14].
Figure 6. Wide-angle XRD pattern of (a) 1Cu-MBG and (b) 5Cu-MBG.
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Figure 7. Mesoporous structures of Cu-doped MBGs: (top) small-angle XRD pattern of (a) 1Cu-MBG
and (b) 5Cu-MBG; (bottom) STEM images of 5Cu-MBG recorded along (c) [100] and (d) [001] directions.
In (d) the typical hexagonal symmetry of the mesopores is emphasized.
STEM images of 5Cu-MBG along the [100] and [001] directions allow the visualization of a highly-
ordered hexagonal arrangement of 1D parallel channels (Figure 7c,d), in agreement with small-angle
XRD results.
N2 adsorption-desorption measurements further confirmed the mesoporous texture of 1Cu-MBG
and 5Cu-MBG as both materials exhibited a type-IV isotherm pattern (Figure 8), which is associated
to nanopores within 2–50 nm [38]. The shape of the hysteresis loop, which can provide information
about the shape of the mesopores [39,40], reveals the presence of uniform mesopores of approximately
cylindrical shape with MCM41-like hexagonal symmetry (H2-type loop). The textural characteristics
are collected in Table 1; these results are consistent with those assessed for the parent SiO2-CaO-P2O5
ternary MBGs [20,41] and suggest that the SSA can be increased by increasing the CuO content in the
glass, which is in agreement with the trend observed by Wu et al. about Cu-doped MBGs [13].
Pore characteristics assessed by micro-CT were in line with previous investigations on SCNA
scaffolds [42]. Interestingly, the presence of the MBG coating induced no significant variations in
terms of macropore size (about 500 µm before and after the coating procedure) while the total porosity
moderately increased after the surface treatment (60 vs. 50 vol. %). This difference can be explained
considering that, in order to apply the MBG coating, SCNA scaffolds were immersed in a strongly
acidic sol having very low value of pH (1.04 and 0.85 for 1Cu-MBG and 5Cu-MBG sols, respectively).
The strong acidity of the sol may be responsible for the surface erosion of scaffold struts, which resulted
in a higher porosity. This had an impact on the mechanical properties, too: in fact, the compressive
strength of both Cu-MBG-SCNA scaffolds was 10.0 ± 2.0 MPa, which is about half as lower as the
compressive strength obtained for uncoated SCNA samples (23.0 ± 2.0 MPa) manufactured through
the same procedure. If application as orbital implant material is a goal, these values of mechanical
strength are enough to allow safe manipulation during surgery as well as postoperative integrity.
Comparison with commercial implants is not possible due to the lack of available data in the literature.
Problems of mechanical integrity were mentioned—albeit without providing quantitative data—for
bovine hydroxyapatite orbital implants [43] that, however, are significantly more porous (80 vol. %)
than the materials developed in the present work.
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Figure 8. Nitrogen adsorption-desorption isotherms of (a) 1Cu-MBG and (b) 5Cu-MBG. Insets in both
pictures report the pore size distribution.
Table 1. Textural parameters obtained by nitrogen adsorption-desorption porosimetry for the calcined
mesoporous materials.
Sample SSA (m2/g) Mean Pore Size (nm)
1Cu-MBG 275 5.1
5Cu-MBG 432 5.1
Figure 9 shows SEM images at different magnifications of 5Cu-MBG-SCNA. In Figure 9a,
the 5Cu-MBG layer is shown to coat quite uniformly the pore walls of the scaffold. As displayed
in Figure 9b, the MBG coating appears to cover all the surface of the single struts lying underneath;
however, some defects and cracks can be observed in the coating, which suggest the need for further
optimization of the deposition procedure and/or calcination treatment to produce flawless glass layers.
The pore/strut architecture of a given scaffold clearly dictates the potential suitability for a specific
application. The total porosity and macropore size of MBG-coated materials are adequate for use
in the field of anopthalmic socket surgery, being comparable to those of commercially-available
and clinically-used orbital implants (see the considerations already presented for SCNA-2Cu and
SCNA-5Cu scaffolds in the Section 3.1).
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Figure 9. SEM micrographs of (a) the porous structure of 5Cu-MBG-SCNA scaffold (magnification
100×) and (b) detail of a trabecula (dashed square in (a)) coated by the MBG layer (magnification 500×).
The release of copper ions from 1Cu-MBG-SCNA and 5Cu-MBG-SCNA scaffolds as a function
of immersion time in SBF is shown in Figure 10. The trend of copper ion release can be split into
three parts: (i) initial increase in the first hours of immersion; (ii) drop observed around 48 h; and (iii)
a plateau stage (1Cu-MBG-SCNA) or a slight increase till 2 weeks (5Cu-MBG-SCNA). The drop of
copper levels might be due to the precipitations of copper in the hydroxyapatite layer that is formed
on the surface of both scaffolds upon immersion in SBF. In fact, it is known that hydroxyapatite can act
as a cation exchanger and may incorporate metallic ions such as Zn, Co and Cu in its structure [44].
Interestingly, weight measurements of scaffolds before and after in vitro tests (2 weeks) revealed
no mass variation during immersion in SBF. Furthermore, pH measurements performed on the testing
solution just revealed a slight variation towards alkalinity (from 7.4 to 7.6).
From these results it is clear that the samples are able to deliver copper ions and that this release
depends on the initial concentration of copper in the MBG formulation. Altogether, the release of copper
ions from 5Cu-MBG-SCNA scaffolds is one order of magnitude larger than that from melt-derived
SCNA-2Cu and SCNA-5Cu at each time point (Figure 10 vs. Figure 5). On the contrary, when results
from 1Cu-MBG-SCNA are compared with those from melt-derived SCNA-2Cu and SCNA-5Cu,
copper ion release appears larger at each time point, yet the values are of the same order of magnitude.
This further confirms that the high SSA of the mesoporous coating facilitates the delivery capacity of
the therapeutic metallic agent. The concentrations of copper released from 5Cu-MBG-SCNA could be
potentially effective to elicit antiseptic and angiogenetic effects [13,34,35], thereby encouraging further
biological investigation on this material.
Figure 10. Profiles of copper release from 1Cu-MBG-SCNA and 5Cu-MBG-SCNA scaffolds following
immersion in SBF.
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Figure 11 shows exemplary SEM images of a 5Cu-MBG-SCNA scaffold after 15 days of immersion
in SBF at different magnifications. The pore walls and struts of the scaffolds are coated by a newly
formed phase characterized by a cauliflower morphology, i.e., globular agglomerates formed by
needle-like nanocrystals. Compositional analysis reveals that this phase is a calcium phosphate with
a Ca-to-P atomic ratio of 1.68, which is very close to that of stoichiometric hydroxyapatite (1.67).
It is worth underlining that, during hydroxyapatite formation, just the scaffold surface (i.e., the thin
surface layer of MBG) reacts with the biological fluids, while the SCNA skeleton exhibits nearly inert
behavior [45]; this fulfils the primary requirement of orbital implant materials, i.e., the stability over
time to allow orbital volume filling and adequate support to surrounding orbital structures.
If apatite-forming ability is unnecessary for orbital implant materials, on the other hand the
bioactivity of the Cu-doped MBG-SCNA scaffold would be key for applications in other biomedical
fields, such as bone tissue repair. Therefore, Cu-doped MBG-SCNA scaffolds show promise for use in
contact with hard tissues to regenerate bone, ensuring structural support at the defect site (due to the
strong SCNA skeleton) as well as promoting bone in-growth and safe anchorage to surrounding host
tissues (due to the MBG layer).
Figure 11. SEM micrographs of 5Cu-MBG-SCNA scaffold after 15 days of immersion in SBF:
(a) overview of the macroporous structure (magnification 200×); (b) newly formed globular agglomerates
on the surface of a trabecula (magnification 3000×); and (c) nanocrystalline nature of this hydroxyapatite-like
phase (magnification 30,000×) characterized by needle-shaped crystals organized according to a typical
cauliflower morphology.
4. Conclusions
Copper, which is known as a proangiogenic and antimicrobial agent, was incorporated into
glass-derived scaffolds via two different approaches. The intended application was in the field of
permanent orbital implant materials and, accordingly, the base material for making scaffolds was
an almost-inert silicate glass. Melt-derived Cu-doped strong macroporous scaffolds were successfully
produced by sponge replication, but the release of copper was inadequate to elicit a therapeutic effect.
The second strategy, involving the deposition of a Cu-doped mesoporous glass layer on the scaffold
struts, allowed achieving a more sustained release of copper, which motivates further research on this
topic. Furthermore, the bioactive glass-coated scaffolds exhibited a good apatite-forming ability upon
immersion in biological fluids, which could suggest promising and interesting applications in other
biomedical areas like bone tissue engineering.
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